Michael Barbella, Managing Editor01.02.24
Rhythmlink International LLC has released a new lineup of concentric needles, augmenting its existing line of products specifically for electromyography (EMG) and nerve conduction velocity (NCV) studies.
The concentric needle is offered in four sizes or gauges, which also vary in needle diameter, length and color, matching currently accepted workflows. The disposable concentric needle pairs with a reusable cable designed specifically to work with Rhythmlink’s needles.
Rhythmlink currently offers a monopolar needle but claims the advantages to this new product family will be appealing to physicians due to clinical studies that suggest using concentric needles allows clinicians to more precisely identify and record from a desired area.
“EMG is an important study for physicians to assess nerve and muscle health, but the market hasn’t changed much in a long time,” said Leah Hanson, vice president of Global Sales and Marketing for Rhythmlink. “Physicians need a product line that can adapt to their needs with high quality signals, consistent product availability, and the ability to customize workflow efficiency. The design of a concentric needle allows for ultra-precise placement and recording, and higher quality readings. It’s a premium product and Rhythmlink is proud to meet this need in the market.”
Since acquiring Chalgren Enterprises in 2020, Rhythmlink has been steadily expanding its product offerings in the EMG and NCV arenas. The concentric needle family joins other recent product releases, such as Sticky Pad Surface Electrodes formulated for NCV, both with and without a leadwire. Additional products available for EMG and NCV studies include a range of detachable and injectable monopolar needles; reusable bar, disc and ring electrodes, and other accessories.
“Offering a full range of products, everything a physician might need, allows us to better serve our customers,” Rhythmlink International Co-Founder/CEO Shawn Regan stated. “That attention to detail and focus on what our customers need is what makes us not just a medical device company, but a true partner to our customers.”
The new Concentric Needle joins a full catalog of products designed for brain health monitoring, EEG Monitoring, ICU and critical care, and more.
Rhythmlink International is a medical device manufacturing company specializing in devices that help connect patients to machines to record or elicit physiologic information. Rhythmlink designs, manufactures and distributes various medical devices for intraoperative neuromonitoring, electroencephalography, evoked potentials, polysomnography, long-term monitoring epilepsy and critical care units. Founded by neurodiagnostic technologists and engineers in 2002, Rhythmlink enhances patient care worldwide by linking patients to equipment. Rhythmlink also offers custom packaging, custom products, private labeling and contract manufacturing services.
The concentric needle is offered in four sizes or gauges, which also vary in needle diameter, length and color, matching currently accepted workflows. The disposable concentric needle pairs with a reusable cable designed specifically to work with Rhythmlink’s needles.
Rhythmlink currently offers a monopolar needle but claims the advantages to this new product family will be appealing to physicians due to clinical studies that suggest using concentric needles allows clinicians to more precisely identify and record from a desired area.
“EMG is an important study for physicians to assess nerve and muscle health, but the market hasn’t changed much in a long time,” said Leah Hanson, vice president of Global Sales and Marketing for Rhythmlink. “Physicians need a product line that can adapt to their needs with high quality signals, consistent product availability, and the ability to customize workflow efficiency. The design of a concentric needle allows for ultra-precise placement and recording, and higher quality readings. It’s a premium product and Rhythmlink is proud to meet this need in the market.”
Since acquiring Chalgren Enterprises in 2020, Rhythmlink has been steadily expanding its product offerings in the EMG and NCV arenas. The concentric needle family joins other recent product releases, such as Sticky Pad Surface Electrodes formulated for NCV, both with and without a leadwire. Additional products available for EMG and NCV studies include a range of detachable and injectable monopolar needles; reusable bar, disc and ring electrodes, and other accessories.
“Offering a full range of products, everything a physician might need, allows us to better serve our customers,” Rhythmlink International Co-Founder/CEO Shawn Regan stated. “That attention to detail and focus on what our customers need is what makes us not just a medical device company, but a true partner to our customers.”
The new Concentric Needle joins a full catalog of products designed for brain health monitoring, EEG Monitoring, ICU and critical care, and more.
Rhythmlink International is a medical device manufacturing company specializing in devices that help connect patients to machines to record or elicit physiologic information. Rhythmlink designs, manufactures and distributes various medical devices for intraoperative neuromonitoring, electroencephalography, evoked potentials, polysomnography, long-term monitoring epilepsy and critical care units. Founded by neurodiagnostic technologists and engineers in 2002, Rhythmlink enhances patient care worldwide by linking patients to equipment. Rhythmlink also offers custom packaging, custom products, private labeling and contract manufacturing services.